Zobrazeno 1 - 10
of 395
pro vyhledávání: '"DOYTCHINOVA IRINI"'
Autor:
CHAKULESKA LIDIJA, SHKONDROV ALEKSANDAR, POPOV GEORGI, ZLATEVA-PANAYOTOVA NADYA, PETROVA RENETA, ATANASOVA MARIYANA, KRASTEVA ILINA, DOYTCHINOVA IRINI, SIMEONOVA RUMYANA
Publikováno v:
Acta Pharmaceutica, Vol 72, Iss 2, Pp 289-302 (2022)
Sophora japonica is a source of several flavonol, flavone and isoflavone glycosides that are reported to positively affect menopausal symptoms including osteoporotic complications. In the present study fructus Sophorae extract (FSE) was administered
Externí odkaz:
https://doaj.org/article/5143aa01c0594f0bb392ff991d4c9f69
Publikováno v:
Cybernetics and Information Technologies, Vol 20, Iss 6, Pp 194-200 (2020)
The AutoImmune ThyroiDitis (AITD), known as Hashimoto’s disease, is a chronic autoimmune thyroid disease progressively developed to hypothyroidism. The AITD is characterized by the formation of autoantibodies targeting two specific thyroid antigens
Externí odkaz:
https://doaj.org/article/893bf153f4544343b6799024a929f98d
Autor:
Doytchinova Irini, Tchorbanov Andrey
Publikováno v:
Cybernetics and Information Technologies, Vol 20, Iss 6, Pp 185-193 (2020)
The ongoing COVID-19 pandemic requires urgently specific therapeutics and approved vaccines. Here, the four structural proteins of the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), the causative agent of COVID-19, are screened by in-h
Externí odkaz:
https://doaj.org/article/eb6dc796842646acbe936cc8c55e9ab9
Autor:
Doytchinova, Irini1 (AUTHOR) idoytchinova@pharmfac.mu-sofia.bg, Atanasova, Mariyana1 (AUTHOR), Sotirov, Stanislav1 (AUTHOR), Dimitrov, Ivan1 (AUTHOR)
Publikováno v:
Pharmaceuticals (14248247). Aug2024, Vol. 17 Issue 8, p1097. 15p.
Autor:
Flower Darren R, Doytchinova Irini A
Publikováno v:
BMC Bioinformatics, Vol 8, Iss 1, p 4 (2007)
Abstract Background Vaccine development in the post-genomic era often begins with the in silico screening of genome information, with the most probable protective antigens being predicted rather than requiring causative microorganisms to be grown. De
Externí odkaz:
https://doaj.org/article/4a09815e59e94bcbbe7a20332a2d48f8
Publikováno v:
BMC Bioinformatics, Vol 7, Iss 1, p 131 (2006)
Abstract Background The main processing pathway for MHC class I ligands involves degradation of proteins by the proteasome, followed by transport of products by the transporter associated with antigen processing (TAP) to the endoplasmic reticulum (ER
Externí odkaz:
https://doaj.org/article/2dd795446c114032af923338c5817000
Autor:
Doytchinova, Irini1 (AUTHOR) idoytchinova@pharmfac.mu-sofia.bg, Atanasova, Mariyana1 (AUTHOR) idimitrov@pharmfac.mu-sofia.bg, Fernandez, Antonio2 (AUTHOR) antonio.fernandezdumont@efsa.europa.eu, Moreno, F. Javier3 (AUTHOR) javier.moreno@csic.es, Koning, Frits4 (AUTHOR) f.koning@lumc.nl, Dimitrov, Ivan1 (AUTHOR)
Publikováno v:
Molecules. Jan2024, Vol. 29 Issue 2, p284. 10p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
EFSA Supporting Publications. Jul2023, Vol. 20 Issue 7, p1-19. 19p.